Vascular endothelial growth factor gene polymorphisms in thyroid cancer

Journal of Endocrinology

Volumn 195, Issue 2, 2007, Pages 265-270

  Hsiao, Pi Jung ^a   Lu, Ming Ying ^b,c   Chiang, Feng Yu ^a   Shin, Shyi Jang ^a,b   Tai, Yu Da ^a,b   Juo, Suh Hang Hank ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Public Health Bureau   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THYROID CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36348982155     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0395     Document Type: Article

References (10)

1. Akslen LA & Livolsi VA 2000 Increased angiogenesis in papillary thyroid carcinoma but lack ofprognostic importance. Human Pathology 31 439-442.
2. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I & Katayama S 2002 A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 1635-1639.
3. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V & Hutchinson IV 1999 Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Human Immunology 60 1245-1249.
4. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, Pierotti MA & Bongarzone I 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid rumors and correlation with clinical pathological features. American Journal of Pathology 155 1967-1976.
5. Carmeliet P & Jain RK 2000 Angiogenesis in cancer and other diseases. Nature 407 249-257.
6. DeLellis R-A, Lloyd RV & Heitz PU 2004 Pathology and genetics of tumor endocrine organs, World Health Organization Classification of Tumors. International Agency for Research on Cancer 8 57-66.
7. Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M & Obara T 1999 Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 126 1056-1061 (discussion 1061-1052).
8. Garvin S, Nilsson UW & Dabrosin C 2005 E&cts ofoestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. British Journal of Cancer 93 1005-1010.
9. Haggstrom S, Lissbrant IF, Bergh A & Damber JE 1999 Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. Journal of Urology 161 1620-1625.
10. Josko J & Mazurek M 2004 Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Medical Science Monitor 10 RA89-RA98.